‘Our discovery, to put it simply - synthetic blood, thanks to which the heart, kidney or liver will remain useful for transplantation for a longer period, and their quality will be better - may significantly affect transplantology’, says chemical engineer, nanotechnologist and biologist Professor Tomasz Ciach.
Adding fermented beetroot and red cabbage to the daily diet can help prevent diet-related diseases, scientists from Olsztyn have shown. They have proven that it can also protect against chronic inflammation in the course of these diseases.
Polish scientists have identified microRNA molecules that may be involved in the pathogenesis of a disease called keratoconus by interfering with key molecular processes, including the organization of the extracellular matrix and signalling.
A non-commercial study by Polish scientists may help reduce the percentage of premature babies with serious breathing disorders, reports the Medical Research Agency, which is financing the project.
A clinical trial focused on the effectiveness of the first vaccine for lung cancer has been launched in Poland, oncologist Professor Dariusz M. Kowalski from the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw confirms. This is a promising method, and patients can still apply for the clinical trial, he adds.
This fluid can replace blood, it can supply oxygen to tissues and remove carbon dioxide from them. We are dealing with a breakthrough when it comes to the future of medicine, says Professor Wojciech Lisik from the Department of General and Transplantation Surgery of the University Clinical Centre of the Medical University of Warsaw.
Remote and hybrid work are more often associated with sleep and circadian rhythm disorders than in-office work, Polish scientists have shown. Performing professional duties from home also increases the risk of musculoskeletal ailments and headaches.
With bacterial resistance to antibiotics being a global health challenge, scientists are looking for new ways to combat microorganisms. A tool designed to accelerate work on new antibacterial compounds has been developed by Dr. Mateusz Rzycki from the Wrocław University of Science and Technology.
The results of the third phase of Lyme disease vaccine trials will most likely be available at the end of 2025, says the president of the Office for Registration of Medicinal Products. If this is confirmed, this long-awaited vaccine could be registered and available in the European Union no earlier than 2026.
Masking autistic traits or adjusting behaviour to the environment are strategies of people with ASD that are part of the so-called social camouflage.